Company: PTHS
Filing Date: 2025-04-17
Form Type: 8-K
Source: 0001753926-25-000652
Chunk: 4

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-04-17
Form: 8-K
Item: Item 1.01
Chunk 4
---
 Stock and
the shares of Common Stock issuable upon conversion of the Series A Preferred Stock issued in the PIPE Financing will be issued
pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (the “ Securities
Act”), and the resale of the shares of Common Stock issuable upon conversion of the Series A Preferred Stock will be
registered pursuant to a resale registration statement (the “ Registration Statement”).

Channel also agreed to defend, indemnify
and hold harmless the PIPE Investors and their respective stockholders, partners, members, officers, directors, employees, direct
or indirect investors, and any of their agents or other representatives against any and all actions, causes of action, suits, claims,
losses, costs, penalties, fees, liabilities and damages, and expenses in connection therewith (including reasonable attorneys’
fees) arising out of or relating to: (i) any misrepresentation or breach of any representation or warranty made by Channel or its
subsidiaries, (ii) any breach of any covenant, agreement or obligation owed by Channel or its subsidiaries, or (iii) any cause
of action, suit, proceeding or claim brought by a third party, including any derivative action, that arises out of or relates to
(A) the execution, delivery, performance or enforcement of the Purchase Agreement and related transaction documents, (B) any transaction
financed or to be financed in whole or in part with the proceeds of the PIPE Financing, or (C) the status of such PIPE Investor
either as an investor in Channel pursuant to the transactions contemplated by the Purchase Agreement or as a party to the Purchase
Agreement and related transaction documents.

Lock-Up Agreements

Concurrently with the execution of the
Securities Purchase Agreement, each of (i) Channel’s and LNHC’s executive officers and directors, (ii) certain investors
who have entered the Securities Purchase Agreement, (iii) a certain investment company and (iv) Nomis Bay and Ligand, have entered
into lock-up agreements (collectively, the “Lock-Up Agreements”), pursuant to which such parties have agreed
not to, except in limited circumstances, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase
any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or
indirectly, any shares of Common Stock or Preferred Stock, from the closing of the Mer